- 1. Tumor
- (UMLS (HL7) C1578706) =Intellectual Product ;
=Specimen Source Codes;
| - 19. Tumor Necrosis Factor Therapy
- (UMLS (NCI) C0279936) =Therapeutic or Preventive Procedure
|
- 2. tumor angiogenesis
- [Proliferation of blood vessels in a tumor. ( NCI )] (UMLS (CSP) C1519670) =Neoplastic Process ;
| - 20. Tumor Promoter
- [An agent that acts at stage 2 of carcinogenesis, following the initiation of increased cell proliferation. It is a necessary step in overt tumor formation. ( NCI )] (UMLS (NCI) C0041370) =Hazardous or Poisonous Substance =Cancer Causing Agents;
=phorbol;
OKA;
thapsigargin |
- 3. Tumor Antigen
- [proteins, glycoproteins or lipoprotein moieties on surfaces of tumor cells that are usually identified by monoclonal antibodies. ( CSP )] (UMLS (NCI) C0041361) =Organic Chemical; Immunologic Factor =antigen;
neoplasm/cancer immunology =AFP;
carcinoembryonal antigen;
synthetic tumor antigen;
API4;
| - 21. Tumor Promoter Induced Gene
- [Tumor promoter induced genes are expressed shortly after cell exposure to tumor promoters. ( NCI )] (UMLS (NCI) C0919533) =Gene or Genome ;
|
- 4. tumor antigen vaccine
- [A vaccine made of tumor antigens (proteins isolated from tumor cells). ( NCI )] (UMLS (NCI) C0279020) =Pharmacologic Substance; Immunologic Factor
| - 22. Tumor Replication Error Analysis
- [Certain tumors contain widespread deletions within mono- and dinucleotide repeat sequences in their DNA, referred to as the replication error (RER+) phenotype. The RER+ status of tumors is usually determined by examining several dinucleotide and mononucleotide repeats for size variations when compared with the matching normal DNA. ( NCI )] (UMLS (NCI) C0796384) =Laboratory Procedure; Research Activity
|
- 5. Tumor Associated Fever
- (UMLS (NCI) C0948348) Tumor-Associated Fever =Neoplastic Process
| - 23. Tumor Stage TX
- [Status of the primary tumor cannot be assessed in accordance with TNM classification system guidelines. (from AJCC 6th Ed.) ( NCI )] (UMLS (NCI) C0332377) =Finding
|
- 6. tumor burden
- [Refers to the number of cancer cells, the size of a tumor, or the amount of cancer in the body. Also called tumor load. ( NCI )] (UMLS (NCI) C1449699) =Diagnostic Procedure ;
| - 24. Tumor Suppressor Candidate 2 Gene
- [This gene plays a putative role in apoptosis and the negative regulation of cell growth. ( NCI )] (UMLS (NCI) C1424700) TUSC2;
TUSC2 Gene =Gene or Genome |
- 7. Tumor Cell Line
- [A cell line derived from cultured tumor cells. ( MSH )] (UMLS (NCI) C0085983) =Cell
| - 25. Tumor Suppressor Protein
- [tumor suppressor gene products; cell cycle regulatory proteins; deregulation is theorized to lead to tumorigenesis. ( CSP )] (UMLS (NCI) C0597611) =Amino Acid, Peptide, or Protein; Biologically Active Substance =Cell Cycle Protein;
=P105-RB;
p53 gene/protein;
|
- 8. Tumor Cell Necrosis
- (UMLS (NCI) C1336835) =Finding ;
| - 26. Tumor Tissue
- [A tissue sample, or entire tumor that is removed for microscopic examination. ( NCI )] (UMLS (NCI) C0475358) =Body Part, Organ, or Organ Component
|
- 9. tumor debulking
- [Surgically removing as much of the tumor as possible. ( NCI )] (UMLS (NCI) C0439805) =Therapeutic or Preventive Procedure
| - 27. Tumor Vascular Invasion
- (UMLS (NCI) C0521157) =Finding
|
- 10. Tumor Embolism
- [A Tumor Embolism involves sudden blockage of an artery by a clot or by other material from tumor fragments transported by the blood stream. ( NCI )] (UMLS (NCI) C0013930) =Neoplastic Process
| - 28. tumor vasculature
- [ ] (UMLS (CSP) C1658953) =Neoplastic Process
|
- 11. Tumor flare
- (UMLS (NCI) C0853891) Tumor Flare Adverse Event;
=Finding ;
| - 29. Tumor-Draining Lymph Node Lymphocyte Therapy
- (UMLS (NCI) C0281444) =Therapeutic or Preventive Procedure
|
- 12. tumor growth
- [ ] (UMLS (CSP) C0598934) =Neoplastic Process ;
| - 30. Tumor-Secreted Protein
- [Proteins or protein fragments secreted from, or shed by, tumor cells. ( NCI )] (UMLS (NCI) C1336834) =Amino Acid, Peptide, or Protein; Indicator, Reagent, or Diagnostic Aid
|
- 13. Tumor Infiltrating Lymphocyte Therapy
- (UMLS (NCI) C0280661) =Therapeutic or Preventive Procedure
| - 31. Tumors of body of uterus complicating pregnancy, childbirth, or the puerperium
- [ ] (UMLS (ICD9CM) C0157011) =Neoplastic Process ;
|
- 14. tumor initiation
- [The first stage of tumor induction by a carcinogen; subtle alteration of cells by exposure to a carcinogenic agent so that they are likely to form a tumor upon subsequent exposure to a promoting agent. (NCI) ( NCI )] (UMLS (CSP) C0598935) =Neoplastic Process
| - 32. Tumors of body of uterus, antepartum condition or complication
- [ ] (UMLS (ICD9CM) C0157015) =Neoplastic Process ;
|
- 15. Tumor Lysis Syndrome
- [A condition of metabolic abnormalities that result from a spontaneous or therapy-related cytolysis of tumor cells. Tumor lysis syndrome typically occurs in aggressive, rapidly proliferating lymphoproliferative disorders. Burkitt lymphoma and T cell acute lymphoblastic leukemia are commonly associated with this syndrome. Metabolic abnormalities include hyperuricemia, lactic acidosis, hyperkalemia, hyperphosphatemia and hypocalcemia and may result in renal failure, multiple organ failure, and death. —2004 ( NCI )] (UMLS (NCI) C0041364) =Disease or Syndrome =Lymphoproliferative Disorder;
neoplastic process | - 33. Tumors of body of uterus, delivered, with mention of postpartum complication
- [ ] (UMLS (ICD9CM) C0157014) =Neoplastic Process ;
|
- 16. Tumor Marker
- [A substance sometimes found in an increased amount in the blood, other body fluids, or tissues and which may mean that a certain type of cancer is in the body. Examples of tumor markers include CA 125 (ovarian cancer), CA 15-3 (breast cancer), CEA (ovarian, lung, breast, pancreas, and gastrointestinal tract cancers), and PSA (prostate cancer). Also called biomarker. ( NCI )] (UMLS (NCI) C0041365) =Biologically Active Substance
| - 34. Tumors of body of uterus, postpartum condition or complication
- [ ] (UMLS (ICD9CM) C0157016) =Neoplastic Process ;
|
- 17. Tumor Necrosis Factor Beta Receptor
- [A 70-kDa high-affinity cell surface receptor for tumor necrosis factor. ( NCI )] (UMLS (NCI) C1447786) Tumor Necrosis Factor Binding Protein 2;
Tumor Necrosis Factor Receptor 2;
Tumor Necrosis Factor Receptor Superfamily, Member 1B;
=Amino Acid, Peptide, or Protein; Immunologic Factor; Receptor | - 35. Tumors of body of uterus, unspecified as to episode of care in pregnancy
- [ ] (UMLS (ICD9CM) C0157012) =Neoplastic Process ;
|
- 18. Tumor Necrosis Factor Receptor Binding
- [Tumor Necrosis Factor Receptor Binding involves a temporary non-covalent highly specific and high affinity interaction through intermolecular physical forces of attraction and spatial complementarity with a group of cell surface intrinsic membrane proteins (alpha and beta TNF Receptors, NGFR family) that mediate the cytotoxic effects of secreted glycoprotein cytokine TNF signaling molecules through modification of the activity of signal transduction pathways to regulate immune responses to infection. ( NCI )] (UMLS (NCI) C1323363) =Molecular Function ;
| - 36. Tumors of body of uterus, with delivery
- [ ] (UMLS (ICD9CM) C0157013) =Neoplastic Process ;
|
home
